Carcinoma, Small Cell

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

ALG-LungCancerRegistry (SAFRO2202)

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer

TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)

Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy

A Phase I Study of iPS Cell Generation From Patients With COPD

BI 2536 Second Line Monotherapy in SCLC

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

Study of Arsenic Trioxide in Small Cell Lung Cancer

Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum

Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma

A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide

A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens

Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer

Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC